Correlation Between Silvercorp Metals and Collegium Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Silvercorp Metals and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silvercorp Metals and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silvercorp Metals and Collegium Pharmaceutical, you can compare the effects of market volatilities on Silvercorp Metals and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silvercorp Metals with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silvercorp Metals and Collegium Pharmaceutical.

Diversification Opportunities for Silvercorp Metals and Collegium Pharmaceutical

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Silvercorp and Collegium is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Silvercorp Metals and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Silvercorp Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silvercorp Metals are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Silvercorp Metals i.e., Silvercorp Metals and Collegium Pharmaceutical go up and down completely randomly.

Pair Corralation between Silvercorp Metals and Collegium Pharmaceutical

Considering the 90-day investment horizon Silvercorp Metals is expected to generate 1.07 times more return on investment than Collegium Pharmaceutical. However, Silvercorp Metals is 1.07 times more volatile than Collegium Pharmaceutical. It trades about 0.07 of its potential returns per unit of risk. Collegium Pharmaceutical is currently generating about -0.02 per unit of risk. If you would invest  329.00  in Silvercorp Metals on November 28, 2024 and sell it today you would earn a total of  35.00  from holding Silvercorp Metals or generate 10.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Silvercorp Metals  vs.  Collegium Pharmaceutical

 Performance 
       Timeline  
Silvercorp Metals 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Silvercorp Metals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Silvercorp Metals displayed solid returns over the last few months and may actually be approaching a breakup point.
Collegium Pharmaceutical 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent essential indicators, Collegium Pharmaceutical is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Silvercorp Metals and Collegium Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Silvercorp Metals and Collegium Pharmaceutical

The main advantage of trading using opposite Silvercorp Metals and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silvercorp Metals position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.
The idea behind Silvercorp Metals and Collegium Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world